Unknown

Dataset Information

0

Cardiomyocyte-specific deletion of GSK-3? leads to cardiac dysfunction in a diet induced obesity model.


ABSTRACT: BACKGROUND AND RATIONALE:Obesity, an independent risk factor for the development of myocardial diseases is a growing healthcare problem worldwide. It's well established that GSK-3? is critical to cardiac pathophysiology. However, the role cardiomyocyte (CM) GSK-3? in diet-induced cardiac dysfunction is unknown. METHODS:CM-specific GSK-3? knockout (CM-GSK-3?-KO) and littermate controls (WT) mice were fed either a control diet (CD) or high-fat diet (HFD) for 55weeks. Cardiac function was assessed by transthoracic echocardiography. RESULTS:At baseline, body weights and cardiac function were comparable between the WT and CM-GSK-3?-KOs. However, HFD-fed CM-GSK-3?-KO mice developed severe cardiac dysfunction. Consistently, both heart weight/tibia length and lung weight/tibia length were significantly elevated in the HFD-fed CM-GSK-3?-KO mice. The impaired cardiac function and adverse ventricular remodeling in the CM-GSK-3?-KOs were independent of body weight or the lean/fat mass composition as HFD-fed CM-GSK-3?-KO and controls demonstrated comparable body weight and body masses. At the molecular level, on a CD, CM-GSK-3? compensated for the loss of CM-GSK-3?, as evident by significantly reduced GSK-3?s21 phosphorylation (activation) resulting in a preserved canonical ?-catenin ubiquitination pathway and cardiac function. However, this protective compensatory mechanism is lost with HFD, leading to excessive accumulation of ?-catenin in HFD-fed CM-GSK-3?-KO hearts, resulting in adverse ventricular remodeling and cardiac dysfunction. CONCLUSION:In summary, these results suggest that cardiac GSK-3? is crucial to protect against obesity-induced adverse ventricular remodeling and cardiac dysfunction.

SUBMITTER: Gupte M 

PROVIDER: S-EPMC5869114 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

Gupte Manisha M   Tumuluru Samvruta S   Sui Jennifer Y JY   Singh Anand Prakash AP   Umbarkar Prachi P   Parikh Shan S SS   Ahmad Firdos F   Zhang Qinkun Q   Force Thomas T   Lal Hind H  

International journal of cardiology 20180203


<h4>Background and rationale</h4>Obesity, an independent risk factor for the development of myocardial diseases is a growing healthcare problem worldwide. It's well established that GSK-3β is critical to cardiac pathophysiology. However, the role cardiomyocyte (CM) GSK-3β in diet-induced cardiac dysfunction is unknown.<h4>Methods</h4>CM-specific GSK-3β knockout (CM-GSK-3β-KO) and littermate controls (WT) mice were fed either a control diet (CD) or high-fat diet (HFD) for 55weeks. Cardiac functio  ...[more]

Similar Datasets

| S-EPMC7093378 | biostudies-literature
| S-EPMC3606001 | biostudies-literature
| S-EPMC3365730 | biostudies-literature
| S-EPMC1964508 | biostudies-literature
| S-EPMC3590116 | biostudies-literature
| S-EPMC4968443 | biostudies-literature
| S-EPMC6645688 | biostudies-literature
| S-EPMC4986641 | biostudies-literature
2019-03-01 | GSE92970 | GEO
| S-EPMC6198345 | biostudies-literature